期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌组织学亚型和药物疗效的关系 被引量：5

下载PDF
导出
摘要 0引言 肺癌是世界范围内引起癌症死亡最常见的原因,发病率以每年3%的速度增长[1]。其中非小细胞肺癌（non-small cell lung cancer,NSCLC）约占肺癌总发病率的75%～85％，2／3确诊时已属晚期，
作者 韩晓 王哲海
机构地区 山东省肿瘤医院内三科
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第9期1084-1087,共4页 Cancer Research on Prevention and Treatment
关键词 非小细胞肺癌 组织学亚型 化疗 靶向治疗 药物疗效
分类号 R730.53 [医药卫生—肿瘤] R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献22

  • 1Michael Pirozynski. 100 years of lung cancer[J].Respir Med, 2006, 100:2073- 2084.
  • 2Travis WD, Brambilla E, Muller Hermelink HK, et al. Pathology and Genetics: Turnouts of the Lung, Pleura, Thymus and Heart[R]. Leon: IARC Press, 2004.
  • 3Peterson P, Hanan N, Fossella F, et al. The differential efficacy of pemetrexed according to NSCLC histology; a review of two Phase III studies[J]. Oncol, 2009, 14(3):253-263.
  • 4Ciuleanu. Pemetrexed/BSC vs Placebo/BSC in NSCLC[R]. Annual Meeting of Clinical Oncology, 2008.
  • 5Scaqliotto GV, Parikh P, Von Pawel J, et al. Phase III Study Comparing Cisplatin Plus Gemcitabine with Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced Stage Non-Small Cell Lung Cancer[J]. J Clin Oncol, 2008, 26 (27) : 3543-3557.
  • 6Burdett S, Stephens R, Stewart L, et al. Chemotherapy in ad- dition to supportive care improves survival in advanced non- small cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials [J]. J Clin Oncol, 2008, 26(28): 4617-4625.
  • 7Ardizzoni A, Boni L, Tiseo M, et al. Cisplatin-versus carbo- platin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-a nalysis[J].J Natl Cancer Inst, 2007, 99(11) : 847-857.
  • 8Georgoulias V, Papadakis E, Alexopoulos A, et al. Platinum- based and nomplatinum based chemotherapy in advanced non- small-cell lung cancer: a randomised muhieentre trial[J]. Lancet, 2001, 35(9267): 1478- 1484.
  • 9Sigmond J, Backus HH, Wouters D, et al. Induction of resistance to the multitargeted antifolate pemetrexed (ALIM TA) in WiDr human coloncancer cells is associated with thymi dylate synthase overcxpression [J]. Biochem Pharmacol 2003, 66(3): 431-438.
  • 10Drake JC, Allegra CJ, Moran RG, et al. Resistance to tomudex (ZD1694) : multifactorial in human breast and colon carci-noma cell lines[J]. Biochem Pharmacol, 1996,51 (10): 1349- 1355.

同被引文献56

  • 1王洲,宋福杰,刘相燕,刘凡英,陈景寒.N_2肺癌预后因素分析及手术适应证的探讨[J].肿瘤防治杂志,2004,11(7):716-719. 被引量：5
  • 2董桂芝,段玉忠,陈正堂.非小细胞肺癌预后相关因素研究进展[J].重庆医学,2006,35(18):1701-1704. 被引量：5
  • 3林贵山,程惠华,傅志超,李东石.晚期非小细胞肺癌同步放化疗的疗效分析[J].中华放射肿瘤学杂志,2006,15(6):462-466. 被引量：21
  • 4Ramalingam S S, Dahlberg S E, Langer C J, et al. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599 [ J]. J Clin Oncol,2008,26( 1 ) :60-65.
  • 5Li Q Q,Xu J D,Wang W J,et al. Twistl-mediated adriamycin- induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells [ J ]. Clin Cancer Res,2009,15( 8 ) :2657- 2665.
  • 6Perez V A,Pajak J F,Rubin P,et al. Long- term observa- tions of the patterns of failure in patients with unresectable non - small cell lung cancer treated with definitive radio- therapy[ J ]. Cancer, 1987,59 : 1874.
  • 7Non - small - Cell Lung Cancer Collaborative Group. Chemotherapy in non - small cell lung cancer : a meta - a- nalysis using updated data on individual patients from 52 randomized clinical trials [ J ]. British Medical Journal, 1995,311 (7010) :899 - 909.
  • 8Ohe Y. Chemoradiotherapy for lung cancer :current status and perspectives [ J ]. Int J Clin Oncol,2004 ,9 :435 - 443.
  • 9Penland S K, Socinski M A. Management of unresectable stage III non - small - cell lung cancer: the role of com- bined chemoradiation [ J ]. Semin Radiat Oncol, 2004,14 : 326 - 334.
  • 10Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in un- resectable stage III non - small cell lung cancer [ J ]. Clin Oncol, 1999,17 (9) : 2692 - 2699.

引证文献5

二级引证文献25

肿瘤防治研究
2010年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部